Evidence map›Paper›PMID 35889688›Full record

ReviewNanomaterials (Basel, Switzerland)2022

Microenvironmental Behaviour of Nanotheranostic Systems for Controlled Oxidative Stress and Cancer Treatment.

Yaser Rehman, Hamzeh Qutaish, Jung Ho Kim, Xu-Feng Huang, Sadia Alvi, Konstantin Konstantinov

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Nano-Based Technology in Glioblastoma.Molecules (Basel, Switzerland) · 2025
    Review
  3. GdVOInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yaser RehmanInstitute for Superconducting and Electronics Materials (ISEM), University of Wollongong (UOW), Wollongong, NSW 2522, Australia.
Hamzeh QutaishInstitute for Superconducting and Electronics Materials (ISEM), University of Wollongong (UOW), Wollongong, NSW 2522, Australia.
Jung Ho KimInstitute for Superconducting and Electronics Materials (ISEM), University of Wollongong (UOW), Wollongong, NSW 2522, Australia.
Xu-Feng HuangIllawarra Health & Medical Research Institute (IHMRI), University of Wollongong (UOW), Wollongong, NSW 2522, Australia.
Sadia AlviDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.
Konstantin KonstantinovInstitute for Superconducting and Electronics Materials (ISEM), University of Wollongong (UOW), Wollongong, NSW 2522, Australia.ORCID 0000-0003-4919-6385
University of Wollongong · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of smart, efficient and multifunctional material systems for diseases treatment are imperative to meet current and future health challenges. Nanomaterials with theranostic properties have offered a cost effective and efficient solution for disease treatment, particularly, metal/oxide based nanotheranostic systems already offering therapeutic and imaging capabilities for cancer treatment. Nanoparticles can selectively generate/scavenge ROS through intrinsic or external stimuli to augment/diminish oxidative stress. An efficient treatment requires higher oxidative stress/toxicity in malignant disease, with a minimal level in surrounding normal cells. The size, shape and surface properties of nanoparticles are critical parameters for achieving a theranostic function in the microenvironment. In the last decade, different strategies for the synthesis of biocompatible theranostic nanostructures have been introduced. The exhibition of therapeutics properties such as selective reactive oxygen species (ROS) scavenging, hyperthermia, antibacterial, antiviral, and imaging capabilities such as MRI, CT and fluorescence activity have been reported in a variety of developed nanosystems to combat cancer, neurodegenerative and emerging infectious diseases. In this review article, theranostic in vitro behaviour in relation to the size, shape and synthesis methods of widely researched and developed nanosystems (Au, Ag, MnO

Indexed as

apoptosiscancercellular internalisationnanotheranosticsoxidative stressoxide nanoparticlesROS

Identifiers

PMID35889688
PMCPMC9319169
OpenAlexW4285729966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.